Patients with chronic prurigo experience high levels of perceived stress, stigmatization and body dysmorphia which are driven ...

Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

A new medicine, Nenolizumab, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat two skin conditions ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for nemolizumab to treat moderate-to-severe prurigo nodularis in adults and moderate-to-severe ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is ...